Lee's Pharmaceutical Holdings Ltd. (0950.HK) reported earnings for full year that Dropped, from the same period last year
The company's bottom line totaled HK$91.94 million, or HK$0.1561 per share. This compares with HK$93.10 million, or HK$0.1581 per share, last year.
The company's revenue for the period rose 2.6% to HK$1.436 billion from HK$1.400 billion last year.
Lee's Pharmaceutical Holdings Ltd. earnings at a glance (GAAP) :
-Earnings: HK$91.94 Mln. vs. HK$93.10 Mln. last year.-EPS: HK$0.1561 vs. HK$0.1581 last year.-Revenue: HK$1.436 Bln vs. HK$1.400 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.